JOSÉ TOMÁS RAMOS AMADOR-rekin lankidetzan egindako argitalpenak (42)

2023

  1. Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial

    eClinicalMedicine, Vol. 60

2022

  1. Children living with HIV in Europe: do migrants have worse treatment outcomes?

    HIV Medicine, Vol. 23, Núm. 2, pp. 186-196

  2. Congenital cytomegalovirus infection in newborns born to HIV-infected mothers

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 10, pp. 557-561

2021

  1. Effects of perinatal HIV-infection on the cortical thickness and subcortical gray matter volumes in young adulthood

    Medicine, Vol. 100, Núm. 15, pp. e25403

  2. Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) study group

    AIDS, Vol. 35, Núm. 12, pp. 1973-1985

2020

  1. Growth Patterns in Children with Congenital Cytomegalovirus Infection

    Pediatric Infectious Disease Journal, pp. 1230-1235

  2. Longitudinal evolution of vertically HIV/HCV–co-infected vs HCV–mono-infected children

    Journal of Viral Hepatitis, Vol. 27, Núm. 1, pp. 61-67

  3. Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Impact of HIV on the health-related quality of life in youth with perinatally acquired HIV

    World Journal of Pediatrics, Vol. 15, Núm. 5, pp. 492-498

  2. Prognostic factors of a lower CD4/CD8 ratio in long term viral suppression HIV infected children

    PLoS ONE, Vol. 14, Núm. 8

  3. Severe haematologic toxicity is rare in high risk HIV-exposed infants receiving combination neonatal prophylaxis

    HIV Medicine, Vol. 20, Núm. 5, pp. 291-307

  4. Sociodemographic changes and trends in the rates of new perinatal HIV diagnoses and transmission in Spain from 1997 to 2015

    PLoS ONE, Vol. 14, Núm. 10

2018

  1. Trends in Drug Resistance Prevalence, HIV-1 Variants and Clinical Status in HIV-1-infected Pediatric Population in Madrid: 1993 to 2015 Analysis

    Pediatric Infectious Disease Journal, Vol. 37, Núm. 3, pp. e48-e57

2017

  1. Dexamethasone for Parapneumonic Pleural Effusion: A Randomized, Double-Blind, Clinical Trial

    Journal of Pediatrics, Vol. 185, pp. 117-123.e6

  2. Erratum to: Safety of zidovudine/lamivudine scored tablets in children with HIV infection in Europe and Thailand (European Journal of Clinical Pharmacology, (2017), 73, 4, (463-468), 10.1007/s00228-016-2182-2)

    European Journal of Clinical Pharmacology

  3. Evaluation of four commercial virological assays for early infant HIV-1 diagnosis using dried blood specimens

    Pediatric Research, Vol. 81, Núm. 1, pp. 80-87

  4. Low Bone Mineral Density in Vertically HIV-infected Children and Adolescents: Risk Factors and the Role of T-cell Activation and Senescence

    Pediatric Infectious Disease Journal

2016

  1. Description and consequences of prescribing off-label antiretrovirals in the Madrid Cohort of HIV-infected children over a quarter of a century (1988-2012)

    Antiviral Therapy, Vol. 21, Núm. 1, pp. 65-70

  2. Diagnóstico precoz de la infección por el virus de la inmunodeficiencia humana-1 en niños: programa de prevención de la transmisión maternoinfantil en Guinea Ecuatorial

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 9, pp. 566-570

  3. Disease disclosure, treatment adherence, and behavioural profile in a cohort of vertically acquired HIV-infected adolescents. NeuroCoRISpeS study

    AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 28, Núm. 1, pp. 124-130